Live Analyst Rating Changes 23586 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Suraj Kalia
OPCO

Suraj Kalia

Oppenheimer
Wall Street Analyst
★★★★☆
#368
on 13Foresight · ranked by our own returns
61%
Success Rate
+32.3%
Average Return
31 of 51 calls profitable · +25.6% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 61% of Suraj Kalia's ratings turned a profit when each position was held for 1 year — averaging +32.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

41 Buy 21 Hold 0 Sell
Suraj's Stock Coverage 43 ratings · 2026-08-12
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
VREX
Varex Imaging
 Aug 11, 2026 HOLD Hold
+21.4% avg upside
9 analysts
$18.90
2.16% Upside
 +0.0% ·
IRTC
Irhythm Technologies
 Aug 10, 2026 BUY Strong Buy
+28.9% avg upside
20 analysts
$185.00
52.85% Upside
 -2.5% ·
AORT
Artivion
 Aug 07, 2026 BUY Strong Buy
+48.6% avg upside
8 analysts
$38.00
42.41% Upside
 +0.0% ·
NYXH
Nyxoah
 Aug 06, 2026 BUY Strong Buy
+797.3% avg upside
12 analysts
$4.00
153.09% Upside
 +12.2% ·
PODD
Insulet
 Aug 05, 2026 HOLD Strong Buy
+50.6% avg upside
32 analysts
 — +8.8% ·
ITGR
Integer Holdings
 Aug 04, 2026 HOLD Buy
-18.1% avg upside
16 analysts
$115.00
8.20% Downside
 -0.0% ·
INSP
Inspire Medical Systems
 Aug 04, 2026 BUY Buy
+42.9% avg upside
21 analysts
$85.00
40.55% Upside
 -9.1% ·
BSX
Boston Scientific
 Jul 30, 2026 BUY Strong Buy
+32.8% avg upside
38 analysts
$85.00
66.79% Upside
 +11.8% ·
GEHC
GE Healthcare Technologies Inc
 Jul 30, 2026 BUY Strong Buy
+13.0% avg upside
22 analysts
$85.00
16.81% Upside
 +3.4% ·
PLSE
Pulse Biosciences
 Jul 28, 2026 BUY Strong Buy
-4.7% avg upside
5 analysts
$35.00
18.96% Downside
 +22.1% ·
ATRC
Atricure
 Jul 24, 2026 HOLD Strong Buy
+8.1% avg upside
13 analysts
 — +22.8% ·
EW
Edwards Lifesciences
 Jul 24, 2026 HOLD Strong Buy
+7.8% avg upside
34 analysts
 — +12.8% ·
KMTS
Kestra Medical Technologies Ltd.
 Jul 21, 2026 HOLD Strong Buy
+0.9% avg upside
9 analysts
 — +25.0% ·
TMDX
TransMedics Group
 May 06, 2026 HOLD Strong Buy
+16.6% avg upside
15 analysts
$175.00
101.53% Upside
 +19.1% ·
ABT
Abbott Laboratories
 Apr 17, 2026 BUY Strong Buy
+5.2% avg upside
36 analysts
$115.00
4.61% Upside
 +13.0% ·
PRCT
PROCEPT BioRobotics
 Feb 26, 2026 HOLD Buy
+42.8% avg upside
17 analysts
$60.00
175.05% Upside
 -9.4% ·
DXCM
Dexcom
 Feb 13, 2026 HOLD Strong Buy
+19.0% avg upside
32 analysts
 — +27.7% ·
ISRG
Intuitive Surgical
 Jan 23, 2026 HOLD Strong Buy
+19.9% avg upside
36 analysts
 — -23.4% ·
TLSI
TriSalus Life Sciences
 Nov 14, 2025 BUY Strong Buy
+71.3% avg upside
8 analysts
$10.00
73.35% Upside
 +23.0% ·
TNDM
Tandem Diabetes Care
 Nov 07, 2025 BUY Buy
+39.8% avg upside
29 analysts
$22.00
5.50% Downside
 +41.0% ·
LMAT
Lemaitre Vascular
 Nov 07, 2025 HOLD Strong Buy
+22.2% avg upside
15 analysts
 — -3.9% ·
RMD
Resmed
 Oct 31, 2025 HOLD Buy
+2.2% avg upside
27 analysts
 — -13.5% ·
OM
Outset Medical
 Aug 07, 2025 HOLD Buy
+246.8% avg upside
8 analysts
 — -65.4% ·
TCMD
Tactile Systems Technology
 Aug 05, 2025 HOLD Strong Buy
+61.8% avg upside
8 analysts
 — +139.1% ·
BFLY
Butterfly Network
 Aug 01, 2025 HOLD Strong Buy
-41.8% avg upside
8 analysts
$3.50
63.23% Downside
 +407.9% ·
HUMA
Humacyte
 Apr 08, 2024 BUY Strong Buy
+823.3% avg upside
11 analysts
 — -62.9% ·
VRAYQ
Viewray
 Jul 18, 2023 HOLD Strong Buy
+558333233.3% avg upside
12 analysts
 — · ·
XAIR
Beyond Air
 Jul 03, 2023 BUY Strong Buy
+1781.2% avg upside
10 analysts
 — · ·
BLFS
BioLife Solutions
 Mar 03, 2023 HOLD Buy
-15.2% avg upside
17 analysts
 — -24.9% ·
CATX
Perspective Therapeutics
 May 11, 2022 BUY Strong Buy
+252.3% avg upside
22 analysts
$1.00
67.44% Downside
 +140.7% ·
TSE:CNVI
Conavi Medical
 Mar 25, 2022 HOLD Buy
+759.1% avg upside
4 analysts
 — · ·
SSKN
Strata Skin Sciences
 Nov 11, 2021 BUY Strong Buy
+5999900.0% avg upside
5 analysts
$4.00
3999899.92% Upside
 -49.4% ·
BAX
Baxter International
 Apr 30, 2021 HOLD Buy
+21.2% avg upside
23 analysts
 — -15.9% ·
NNOX
Nano-X Imaging
 Apr 05, 2021 HOLD Strong Buy
+741.7% avg upside
7 analysts
 — · ·
MDT
Medtronic
 Sep 25, 2019 HOLD Buy
+6.9% avg upside
38 analysts
$100.00
10.69% Upside
 -1.4% ·
HIND
Vyome Holdings
 Sep 09, 2019 HOLD Strong Buy
+1300.2% avg upside
8 analysts
 — · ·
SRTS
Sensus Healthcare
 Aug 09, 2019 SELL Buy
+118.7% avg upside
8 analysts
$5.00
63.23% Upside
 +48.9% ·
VIVE
Viveve Medical
 Jul 23, 2019 HOLD Buy
+79999900.0% avg upside
8 analysts
 — · ·
EYPT
EyePoint Pharmaceuticals
 Feb 08, 2018 BUY Strong Buy
+161.1% avg upside
20 analysts
$4.00
68.30% Downside
 +123.4% ·
MDXG
MiMedx Group
 Oct 30, 2015 BUY Strong Buy
+148.5% avg upside
17 analysts
$10.00
131.54% Upside
 +20.6% ·
ADYX
Adynxx
 Feb 24, 2015 BUY Strong Buy
+3387400.1% avg upside
4 analysts
$8.00
7999899.93% Upside
 · ·
FOCL
EDAP TMS
 Sep 29, 2014 HOLD Buy
+37.2% avg upside
8 analysts
 — +327.1% ·
XTNT
Xtant Medical Holdings
 Mar 20, 2014 BUY Strong Buy
+1728.2% avg upside
9 analysts
$20.00
5680.25% Upside
 · ·
🔒 38 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Suraj Kalia — Frequently Asked Questions
How accurate are Suraj Kalia's stock ratings?
Based on the calls 13Foresight could measure, about 61% of Suraj's ratings were profitable over a one-year hold, with an average return of +32.3% per rating, or +25.6% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Suraj ranked on 13Foresight?
Suraj Kalia is currently ranked #368 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Suraj cover?
Suraj most recently has ratings on VREX, IRTC, AORT, NYXH, PODD, ITGR, INSP, BSX, GEHC, PLSE, ATRC, EW and 31 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.